Skip (8)
Oct 12, 2022


Yesterday was FDA's NANODAY.

This symposium will address drug development of products that contain nanomaterials in their formulation and how the newly finalized guidance to the industry for products that contain nanomaterials can be implemented in filings to the FDA. FDA speakers will present reviewer perspectives on drug development and laboratory efforts to facilitate further understanding of challenges to manufacturing products that contain nanomaterials. Two additional speakers will address safety evaluations of food contact substances that contain nanomaterials and the development of standard materials and methods for nanomaterials.

You must have a Gab account and be logged in to comment.

    Modal title